Nonprofit buys experimental cancer drug to maintain patient access
In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug.
Opening excerpt (first ~120 words) tap to expand
Health Nonprofit buys experimental cancer drug to maintain patient access Blood Cancer United is buying remaining supplies of Luvelta, and will manage a compassionate-use program Manage alerts for this article Email this article Share this article Adobe By Lauren ChanJune 11, 2026 AAAS Mass Media Science & Engineering Fellow Lauren Chan[email protected]Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space. In a rare move, nonprofit organization Blood Cancer United announced Thursday it was buying the remaining supplies of Luvelta, a discontinued investigational cancer drug.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at STAT.
Discussion
0 commentsMore from STAT
